Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
5.96%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth5.96%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
73.63%
60%
—
—
Never
—
5 Years
Score—
Net Growth73.63%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Anebulo Pharmaceuticals Inc fundamental performance
Across Anebulo Pharmaceuticals Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 30M to -$ 8M. Revenue increased in 0% of the years measured; net income in 60%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-11 | $ 0.30 | — |
1 Year2025-08-12 | $ 2.38 | -87.39% |
5 Years2021-08-12 | $ 7.32 | -95.90% |
All Time2021-05-07 | $ 7.10 | -95.77% |
| Period | Last Price2026-08-11 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-05-07 |
|---|---|---|---|---|
| Price | $ 0.30 | $ 2.38 | $ 7.32 | $ 7.10 |
| Return | — | -87.39% | -95.90% | -95.77% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 7M | $ 9M |
| 2025 | $ 0.00 | -$ 8M | $ 11M |
| 2024 | $ 0.00 | -$ 8M | $ 3M |
| 2023 | $ 0.00 | -$ 11M | $ 11M |
| 2022 | $ 0.00 | -$ 6M | $ 14M |
| IPO2021 | $ 0.00 | -$ 30M | $ 19M |
Explore beyond ANEB
You're looking at Anebulo Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
